Inhaled nitric oxide in cardiac failure: Vascular versus ventricular effects

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 1, 1996, Pages 80-85

  Hayward, C S ^a   Rogers, P ^a   Keogh, A M ^a   Kelly, R ^a   Spratt, P M ^a   Macdonald, P S ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Cardiac failure; Inhalation; Negative inotropic action; Nitric oxide; Pulmonary hypertension; Vasodilator

Indexed keywords

NITRIC OXIDE;

ADULT; ARTICLE; BLOOD VESSEL TONE; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HEART CATHETERIZATION; HEART FAILURE; HEART FUNCTION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INOTROPISM; LUNG CAPILLARY PRESSURE; MALE; NEUROTRANSMISSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VASCULAR RESISTANCE;

ADMINISTRATION, INHALATION; ADULT; BLOOD PRESSURE; HEART DISEASES; HUMANS; HYPERTENSION, PULMONARY; MIDDLE AGED; NITRIC OXIDE; PULMONARY WEDGE PRESSURE; VASCULAR RESISTANCE;

EID: 0030032826     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199601000-00013     Document Type: Article

References (26)

1. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
2. Rimar S, Gillis CN. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation 1993;88:2884-7.
3. Roberts JD, Polaner DM, Lang P. Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:819-20.
4. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328:399-405.
5. Adatia I, Lillihei C, Arnold JH, et al. Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation. Ann Thorac Surg 1994;57:1311-8.
6. Macdonald PS, Mundy J, Rogers P, et al. Successful treatment of life-threatening acute reperfusion injury after lung transplantation with inhaled nitric oxide. J Thorac Cardiovasc Surg 1995;110:861-3.
7. Girard C, Lehot JJ, Pannetier J, Filley S, French P, Estanove S. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 1992;77:880-3.
8. Girard C, Durand PG, Vedrinne C, et al. Case 4 - inhaled nitric oxide for right ventricular failure after heart transplantation. J Cardiovasc Anaesth 1993;7:481-5.
9. Roberts J, Land P, Bigatello L, Vlahakes G, Zapol W. Inhaled nitric oxide in congenital heart disease. Circulation 1993;87:447-53.
10. Kieler-Jensen N, Rickstein S-E, Stenqvist O, et al. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. J Heart Lung Transplant 1994;13:366-75.
11. Semigran MJ, Cockrill BA, Kacmarek R, et al. Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol 1994;24:982-8.
12. Loh E, Stamler JS, Hare JM, Loscalzo J, Colucci WS. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation 1994;90:2780-5.
13. Michel T, Smith TW. Nitric oxide synthases and cardiovascular signalling. Am J Cardiol 1993;72:33C-8C.
14. Balligand J-L, Ungureanu D, Kelly RA, et al. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 1993;92:2314-9.
15. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hauler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257:387-9.
16. De Belder AJ, Radomski MW, Why HJF, et al. Nitric oxide synthase activities in human myocardium. Lancet 1993;341:84-5.
17. Kirklin JK, Naftel DC, Kirklin JW, Blackstone EH, White-Williams C, Bourge RC. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Lung Transplant 1988;7:331-6.
18. Foubert L, Fleming B, Latimer R. et al. Safety guidelines for use of nitric oxide. Lancet 1992;339:1615-6.
19. Miller OI, Celermajer DS, Deanfield JE, Very-low-dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Surg 1994;108:487-94.
20. Gerlach H, Pappert D, Lewandowski K, Rossaint R, Falke KJ. Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory syndrome. Intensive Care Med 1993; 19:443-9.
21. Puybasset L, Rouby JJ, Mourgeon E, et al. Inhaled nitric oxide in acute respiratory failure: dose-response curves. Intensive Care Med 1994;20:319-27.
22. Fort S, Lewis MJ, Shah AM. The role of endocardial endothelium in the modulation of myocardial contraction in the isolated whole heart. Cardioscience 1993;4:217-23.
23. Stamler JS, Jaraki O, Osborne J, et al. Nitric oxide circulates in mammalian plasma primarily as an 5-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 1992;89:7674-7.
24. Paulus W, Vantrimpont PJ, Shah AM. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Circulation 1994;89:2070-8.
25. Bocchi EA, Bacal F, Auler JOC Jr, et al. Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure. Am J Cardiol 1994;74:70-3.
26. Zapol WM, Rimar S, Gillis N, Marietta M, Basken CH. NHLBI Workshop summary: nitric oxide and the lung. Am J Respir Crit Care 1994;149:1375-80.